Burning Rock Biotech (BNR) Liabilities and Shareholders Equity (2019 - 2025)

Burning Rock Biotech's Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $115.7 million for Q4 2025.

• In Q4 2025, Liabilities and Shareholders Equity fell 6.15% year-over-year to $115.7 million; the TTM figure through Dec 2025 stood at $460.8 million (down 14.89% YoY), while the FY2025 annual figure was $115.7 million, down 4.63% from the prior year.
• Liabilities and Shareholders Equity was $115.7 million for Q4 2025 at Burning Rock Biotech, up from $113.5 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $409.4 million in Q1 2021 to a low of $113.5 million in Q3 2025.
• Historically, Liabilities and Shareholders Equity has averaged $216.0 million across 5 years, with a median of $175.0 million in 2023.
• The sharpest annual moves came in 2021 and 2023: Liabilities and Shareholders Equity dropped 5.53% in 2021, then slumped 37.62% in 2023.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $356.4 million in 2021, then slumped by 37.37% to $223.2 million in 2022, then tumbled by 35.29% to $144.4 million in 2023, then dropped by 14.67% to $123.2 million in 2024, then slipped by 6.15% to $115.7 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $115.7 million (Q4 2025), $113.5 million (Q3 2025), and $114.0 million (Q2 2025), per Business Quant data.